UBS Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

UBS Group’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-700	Closed	-$8K	–	10185
2014 Q4	$8K	Buy	+700	New	+$10.6K	﹤0.01%	8671

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

UBS Group's BDSI Position: Q1 2022 in Review

UBS Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 154,177 shares — an estimated $479K sold.

UBS Group first reported a position in BDSI in Q4 2014 and held it in 29 quarters. The position peaked at $4.14M in Q4 2020. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

UBS Group reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
UBS Group sold 154,177 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $479K.
UBS Group first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 29 quarters.
UBS Group's BioDelivery Sciences International, Inc. position peaked at $4.14M in Q4 2020.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.